Harry Tam
Foot & Ankle Surgery · Dover, DENPI 1235231945
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,172 of the $5,215 with a category attached, or 60.8%. 10 manufacturers reported payments, led by Arthrex at 40.8% of the total. Reporting peaked in 2019 at $2,689 and has fallen 95.0% since, to $133 in 2025.
Across 24 payments — averaging $217.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Supreme Orthopedic Systems, LLC$2K
- Novus Surgical Consultants$465
- Stryker$313
- Biocomposites Inc$146
- Integra Lifesciences Corporation$117
- plus $293 from 4 others
What the payments were for
- Travel & lodging$53410%
- Food & beverage$1,50929%
- Education$3,17261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $2,126 |
| Supreme Orthopedic Systems, LLC | 4 | $1,755 |
| Novus Surgical Consultants | 4 | $465 |
| Stryker | 3 | $313 |
| Biocomposites Inc | 1 | $146 |
| Integra Lifesciences Corporation | 1 | $117 |
| Paragon 28, Inc. | 2 | $116 |
| Treace Medical Concepts, Inc. | 1 | $79 |
| Smith+Nephew | 3 | $76 |
| Medtronic | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$351
- Stimulan$146
- INFINITY ADAPTIS$133
- PHALINX$125
- DISTAL EXTREMITIES IMPLANTS NITINOL OTHER$124
- INTEGRA DERMAL REGENERATION TEMPLATE$117
- PRIMATRIX$117
- Product Portfolio$103
How this compares
$5,215 in reported general payments places this provider in the 65th percentile of 32 foot & ankle surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 75 | $1,196 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $1,084 |
| Gabapentin | 88 | $1,069 |
| Ketoconazole | 52 | $868 |
| Ciclopirox | 36 | $800 |
| Ammonium Lactate | 60 | $769 |
| Econazole Nitrate | 18 | $666 |
| Doxycycline Monohydrate | 27 | $437 |
| Diclofenac Sodium | 31 | $399 |
| CiclopiroxCiclopirox Olamine | 14 | $388 |
| Cephalexin | 46 | $341 |
| Terbinafine Hcl | 34 | $305 |
| Celecoxib | 12 | $253 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $180 |
| Triamcinolone Acetonide | 12 | $147 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Dover
- Jacob HanlonDover$50K
- Jamie HopkinsDover$711
- Fanta Morgan KitsonDover$29
- Cody BowersWilmington$14K
- Brendan KaneLewes$11K
- Bradley LemonSeaford$10K
- Kirstyn UrbasNewark$7K
- Korey DuboisWilmington$7K
- Katrin HeinemanWilmington$6K
- Katherine PersckyWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.